Sep 03, 2026
698:675
For every 675 shares held, investors received 698. The price per share adjusted from $54000.00 to $52220.63.
The split itself did not change the total investment value.
L&C BIO Co., Ltd. (KRX:290650) operates in the Medical specialties industry.
L&C BIO Co., Ltd. company overviewL&C BIO Co., Ltd.'s most recent stock split was on September 3, 2026. It was a 698-for-675 forward split, so shareholders received 698 shares for every 675 they held.
L&C BIO Co., Ltd. (KRX:290650) has split its stock 2 times: a 3-for-1 split on October 12, 2020 and a 698-for-675 split on September 3, 2026.
L&C BIO Co., Ltd. has split its stock 2 times. This history records 2 forward splits between October 12, 2020 and September 3, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In L&C BIO Co., Ltd.'s 698-for-675 split on September 3, 2026, every 675 shares became 698 shares.
L&C BIO Co., Ltd. has not announced a new split in our records. Its most recent split was on September 3, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:290650 split will appear on this page.
Already premium?